The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 08, 2025

Filed:

Apr. 20, 2020
Applicants:

Jecho Institute, Co., Ltd., Shanghai, CN;

Jecho Laboratories, Inc., Frederick, MD (US);

Inventors:

Jianwei Zhu, Shanghai, CN;

Jing Wang, Shanghai, CN;

Junsheng Chen, Shanghai, CN;

Yueqing Xie, Shanghai, CN;

Hua Jiang, Shanghai, CN;

Huifang Zong, Shanghai, CN;

Lei Han, Shanghai, CN;

Assignees:

Jecho Institute, Co., Ltd., Shanghai, CN;

Jecho Laboratories, Inc., Frederick, MD (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/62 (2006.01); C07K 14/47 (2006.01); C07K 19/00 (2006.01); C12N 5/10 (2006.01); C12P 21/02 (2006.01);
U.S. Cl.
CPC ...
C12N 15/62 (2013.01); C07K 14/47 (2013.01); C07K 19/00 (2013.01); C12N 5/10 (2013.01); C12P 21/02 (2013.01);
Abstract

Provided is a polypeptide combination, a targeting component thereof comprising a shielding peptide, a cleavable part, an antigen-binding part and a first intein fragment, the shielding peptide and the antigen-binding part being connected by means of the cleavable part, and the antigen-binding part being directly or indirectly connected to the first intein fragment; a toxin component thereof comprises a second intein fragment and a toxin, and the second intein fragment is directly or indirectly connected to the toxin; the targeting component and the toxin component form an immunoconjugate by means of the interactive action between the first intein fragment and the second intein fragment; in the immunoconjugate, the shielding peptide and the antigen-binding part are connected by means of the cleavable part, and the antigen-binding part is connected to the toxin. Also provided are a preparation method and a pharmaceutical use for the polypeptide combination.


Find Patent Forward Citations

Loading…